Frequently Asked Questions about GE HealthCare Technologies Inc. (GEHC)

Name: GE HealthCare Technologies Inc. (GEHC) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does GE HealthCare Technologies Inc. (GEHC) do?

Accepted Answer

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong ...

Question 2

Is GE HealthCare Technologies Inc. (GEHC) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of GEHC reveals an Altman Z-Score of 1.75 and a Piotroski F-Score of 7/9. These metrics, combined with its 5-year revenue trend ($20.63B most recent), help investors decide if GEHC fits their risk profile.

Question 3

What is the current P/E ratio for GEHC?

Accepted Answer

As of the latest trading session, GE HealthCare Technologies Inc. (GEHC) has a trailing P/E ratio of 19.13.

Question 4

Who is the CEO of GE HealthCare Technologies Inc.?

Accepted Answer

The current Chief Executive Officer of GE HealthCare Technologies Inc. is Peter J. Arduini.

Question 5

What was GEHC's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, GE HealthCare Technologies Inc. reported annual revenues of $20.63B (2025), $19.67B (2024), $19.55B (2023), $18.34B (2022), $17.59B (2021) respectively.

Question 6

Does GEHC pay a dividend?

Accepted Answer

GE HealthCare Technologies Inc. currently pays a dividend to its shareholders, with a trailing dividend yield of 0.20%.

Question 7

How much debt and cash flow does GEHC have?

Accepted Answer

In its latest reporting period, GE HealthCare Technologies Inc. generated $1.51B in Free Cash Flow against a total debt load of $10.00B.

Question 8

What is the Price-to-Book (P/B) ratio of GE HealthCare Technologies Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for GE HealthCare Technologies Inc. (GEHC) is currently 3.10.

Question 9

What is the Price-to-Sales (P/S) ratio of GEHC?

Accepted Answer

Based on trailing twelve-month data, GE HealthCare Technologies Inc. (GEHC) trades at a Price-to-Sales (P/S) ratio of 1.64.

Question 10

What is GE HealthCare Technologies Inc.'s Return on Equity (ROE)?

Accepted Answer

GE HealthCare Technologies Inc. (GEHC) has a Return on Equity (ROE) of 17.11%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	2B	130M	-482M	1.5B	1.4B
2024-12	2B	125M	-401M	1.6B	1.4B
2023-12	2.1B	114M	-387M	1.7B	1.6B
2022-12	2.1B	67M	-310M	1.8B	1.7B
2021-12	1.6B	76M	-248M	1.4B	1.3B

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	2B	130M	-482M	1.5B	1.4B
2024-12	2B	125M	-401M	1.6B	1.4B
2023-12	2.1B	114M	-387M	1.7B	1.6B
2022-12	2.1B	67M	-310M	1.8B	1.7B
2021-12	1.6B	76M	-248M	1.4B	1.3B